Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 4Breast Neoplasms 4Sarcoma 2Ovarian Neoplasms 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Head and Neck Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Burkitt Lymphoma 2Astrocytoma 2Spinal Cord Neoplasms 1Recurrence 1Radiation Injuries 1Radiation Fibrosis Syndrome 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Optic Nerve Glioma 1Medulloblastoma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, AIDS-Related 1Lymphoma 1Lymphedema 1Localized Advanced Rectal Adenocarcinoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Acute 1

Interventions

trastuzumab biosimilar HLX02 1pertuzumab 1Trastuzumab 1Taxes 1Surgical Procedures, Operative 1Radiotherapy 1Radiation 1Paclitaxel 1PF-05280014 1Ontruzant 1Ogivri 1Mastectomy, Segmental 1Mastectomy 1Magnetic Resonance Spectroscopy 1Fluorodeoxyglucose F18 1Drug Therapy 1Docetaxel 1Albumin-Bound Paclitaxel 1Ado-Trastuzumab Emtansine 12C4 antibody 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Anatomic Stage II Breast Cancer AJCC v8 × Drug Therapy × Clear all
NCT05710328 2026-05-05

Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
235 enrolled
Breast

Anatomic Stage II Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡